Clinical trials / NCT06799247
NCT06799247Phase 3Active not recruiting

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Study sponsor: Cartesian Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-12-30Estimated
Enrollment · participants128Actual
Source updated2026-09-01Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 4 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

100 participants (planned)

+ After

128 participants (actual)

Primary completion date changed

− Before

30 Nov 2026

+ After

30 Dec 2026

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source